Picture of BioXcel Therapeutics logo

BTAIQ — BioXcel Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

BioXcel Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

* BioXcel Therapeutics Inc  BTAI.OQ  reported a quarterly
adjusted
loss of 32 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of $-1.72.  The mean expectation of six analysts
for the quarter was for a loss of 54 cents per share. Wall
Street expected results to range from -73 cents to -44 cents per
share.
    * Revenue fell 37.2% to $214.00 thousand from a year ago;
analysts
expected $1.31 million. 
    * BioXcel Therapeutics Inc's reported EPS for the quarter
was a
loss of 32 cents​.
    * The company reported a quarterly loss of $13.65 million.
    * BioXcel Therapeutics Inc shares had risen by 1.5% this
quarter and lost 79.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for BioXcel
Therapeutics Inc is 6.00 
This summary was machine generated from LSEG data November 14 at
08:58 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.54          -0.32          Beat
 Jun. 30 2024      -0.71          -0.21          Beat
 Mar. 31 2024      -0.70          -0.87          Missed
 Dec. 31 2023      -0.91          -0.76          Beat

Recent news on BioXcel Therapeutics

See all news